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1. Introduction 
Ovarian folliculogenesis is characterized by drastic proliferation and differentiation of 
granulosa cells and theca cells. Although it is well accepted that gonadotropins and ovarian 
steroids play the central roles in follicular development by controlling follicular 
microenvironments, intrafollicular substances including growth factors and cytokines are 
known to function as modulators of ovarian follicular growth and development. 
Differentiation of granulosa cells involves follicle-stimulating hormone (FSH)-induced 
maturation of immature cells into mature cells. The expressions of related genes are rigidly 
controlled until ovulation, and then granulosa and theca cells are finally differentiated into 
luteal cells, which produce progesterone. On the other hand, the uterus is closely 
synchronized to the ovary: increasing ovarian steroids regulate the uterus as one of the 
principal targets to prepare for embryo implantation following fertilization. In the uterus—
composed of heterogeneous cell types including luminal and glandular epithelial cells, 
stroma cells, and muscle layers—estradiol stimulates the proliferation of epithelial cells, 
whereas progesterone inhibits estradiol-induced hyperplasia of the epithelial compartments 
(Carson et al., 2000). In rodents, the endometrial stroma cells undergo proliferation and 
decidualization in response to ovarian steroids and embryo implantation at the early stage 
of pregnancy (Clarke & Sutherland, 1990; Dey et al., 2004). Thus, cellular functions in the 
ovary and uterus are accompanied by cyclic changes of cell proliferation, differentiation and 
apoptosis. The circadian clock system may contribute to the progress of follicular 
development, luteinization and luteolysis, and steroid hormone-induced proliferation and 
differentiation of uterine cells through fluctuating hormones. Recently, there is a growing 
body of evidence that circadian clock genes are expressed in reproductive tissues including 
the ovary and uterus (Johnson et al., 2005; Nakamura et al., 2005; Fahrenkrug et al., 2006; 
Dolatshad et al., 2006; Karman & Tischkau, 2006; He et al., 2007a, 2007b, 2007c; Nakao et al., 
2007; Hirata et al., 2009; Sellix & Menaker, 2010; Uchikawa et al., 2011). Many regulatory 
elements are located at the upstream of clock genes, such as steroid hormone response 
element half-sites and the adenosine 3’,5’-cyclic monophosphate (cAMP) response element 
site as well as E-box and D-box elements. The mammalian circadian system is composed of 
three components: input pathways, central pacemaker, and output pathways. The input 
pathways transmit environmental signals to the central pacemaker, which coordinates the 
external signals with the central endogenous rhythm of the body by neural, hormonal and 
behavioural cues (Reppert & Weaver, 2001; Schibler & Sassone-Corsi, 2002; Yamamoto et al., 
www.intechopen.com
 Update on Mechanisms of Hormone Action – Focus on Metabolism, Growth and Reproduction 
 
218 
2004; Duguay & Cermakian, 2009). At the molecular level, the circadian systems through 
expression of clock genes generate circadian changes in cell functions via identified 
transcriptional and posttranscriptional regulatory processes. The CLOCK-BMAL1 
heterodimers formed by the bHLH-PAS-activating clock-controlled genes, including Per, 
CKIε, Clock, Bmal1, and Cry, bind to the canonical E-box element of these promoters and 
initiate the transcription activities of these genes. The PER and CRY proteins, in turn, form 
multimeric complexes and feed back to repress the transactivation by CLOCK/BMAL1 in 
the nucleus (Ueda et al., 2005). The peripheral oscillators, synchronized by the central clock, 
control the expression of downstream clock-controlled genes in tissue-specific relationships. 
Here, the hormonal regulation of the circadian clock system in ovarian and uterine cells is 
reviewed and studied in rats. The study indicated that the circadian pacemaker is altered in 
ovarian and uterine cells during cellular differentiation, which is induced by hormonal 
stimulation. 
2. Real-time monitoring of circadian oscillation in primary cultured cells 
Cell lines such as fibroblasts also display several oscillations of the clock gene expression 
when treated with dexamethasone, serum shock or other stimuli (Balsalobre et al., 2000a, 
2000b). To precisely analyze the circadian clock system, a real-time system for monitoring 
gene expression has been employed using transgenic rats constructed with mouse Per2 
 
 
Fig. 1. Profiles of circadian Per2-dLuc oscillations in ovarian granulosa cells (GC), uterine 
endometrial stroma cells (UESC) and testicular interstitial fibroblast-like cells (TIFC) treated 
with dexamethasone. The values are the peak times (hours) in each oscillation. 
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promoter-destabilized luciferase (Per2-dLuc) reporter gene (Ueda et al., 2002). Transgenic rats 
were maintained under 12-h L and 12-h D (zeitgeber time, ZT0; 08:00 h light on; ZT12: 20:00 
h light off). Three cell types were prepared from the ovary, uterus and testis: i.e., ovarian 
granulosa cells, uterine endometrial stroma cells and testicular interstitial fibroblast-like 
cells. These cell types exhibited several oscillations after exposure to dexamethasone, but the 
number of oscillations for each cell type was distinct (Fig. 1). The times of the second 
oscillation were 27.35 h in the granulosa cells, 29.26 h in the stroma cells, and 31.20 h in the 
testicular interstitial fibroblast-like cells, but the cycle times were similar (~24 h). 
3. Circadian rhythm in ovarian cells under hormonal stimulation 
Several laboratories have reported the expression of clock genes in the ovarian follicles and 
corpora lutea in vivo, but their conclusions are mostly conflicting. Studies on the circadian 
clock in the Drosophila ovary suggested that period and timeless were constantly expressed in 
the follicular cells (Beaver et al., 2003). The diurnal rhythms of Per1 and Per2 expression 
were reported in the corpora lutea of rat ovaries (Fahrenkrug et al., 2006). In contrast, Bmal1 
and Per2 were rhythmically expressed in the rat ovarian follicles but not in the corpora lutea 
(Karman & Tischka, 2006). In the current study, preantral and antral ovarian follicles of 
immature transgenic rats were primed with diethylstilbestrol and equine chorionic 
gonadotropin (eCG), respectively (Fig. 2, A), to obtain granulosa cells. In both cell types, an 
oscillation of Per2 promoter activity was observed at approximately 4 h after exposure to 
dexamethasone. While oscillation was induced in both, the oscillatory patterns of two cell 
types were different. In the granulosa cells from preantral follicles only one weak oscillation 
was induced, subsequent to the initial oscillation, which occurred at approximately 24 h 
(Fig. 2, B & C). Conversely, a few robust oscillations were detected in the granulosa cells 
from antral follicles, albeit with a continuous decreasing of amplitude (He et al., 2007a). FSH 
was also effective at inducing the oscillation seen at approximately 24 h (Fig. 2, C). This 
distinctness may be related to each cellular physiology. Granulosa cells spontaneously 
undergo cellular apoptosis in vitro (Tilly et al., 1992). However, it is unlikely that the cell 
death caused the cessation of oscillation in the granulosa cells after only one cycle, as 90% of 
the cells were still viable, and additional oscillation could be evoked by replacement with 
fresh medium or stimulation with forskolin (Fig. 2, B). This finding suggests that, in vivo, the 
circadian clockwork is somewhat influenced in follicular granulosa cells during the process 
of cell differentiation or maturation. The clock system was also analyzed in the luteal cells 
that were prepared from ovaries of immature rats primed by eCG and human chorionic 
gonadotropin (hCG). The luteal cells exhibited several circadian oscillations with high 
amplitude after exposure to forskolin or dexamethasone (Fig. 2, D). However, the oscillation 
shifted forward approximately 3 h when the cells were treated with forskolin. The profiles 
of oscillation for dexamethasone and forskolin treatments were distinct, although the cycle 
times were the same, approximately 24 h. The first oscillation was found at 3-5 h after the 
initiation of monitoring, although the time was dependent upon the stimulant. LH was also 
effective at inducing circadian oscillation in luteal cells (Fig. 2, D). 
4. Circadian rhythm in uterine cells under hormonal stimulation 
Ovarian steroids regulate the proliferation and differentiation of uterine endometrial stroma 
cells (Carson et al., 2000). In addition, in the rat Per2 gene, many estrogen response element 
(ERE) half-sites and progesterone response element (PRE) half-sites are located at the 
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Fig. 2. Circadian oscillation of Per2-dLuc in granulosa cells and luteal cells. A, Observation of 
the PER2 protein in preantral (DES injection for 3 days) and antral (eCG injection) follicles of 
ovaries by fluorescent immunohistochemistry. GC, granulosa cells; O, oocytes. Scale bar, 50 
µm. B, The granulosa cells isolated from preantral follicles were cultured for 48 h with medium 
containing 5% FBS. The oscillation of Per2-dLuc was induced after exposure to dexamethasone 
(a). Culture medium containing with (c) or without (b) 10 µM forskolin was replaced at 48 h 
after the initiation of bioluminescent monitoring. C, Granulosa cells from preantral (a) and 
antral follicles (b, c) were cultured as described above and treated with dexamethasone (a, b) 
for 2 h, and then subjected to real-time monitoring of bioluminescence. FSH was contained in 
the culture medium during monitoring (c). D, Luteal cells prepared from luteinized ovaries of 
rats primed by eCG and hCG were cultured as described above and treated with forskolin (a) 
or dexamethasone (b) for 2 h, and then subjected to real-time monitoring of bioluminescence. 
LH was contained in the culture medium during monitoring (c). 
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upstream of the transcription start site. These sites may contribute to the expression of the 
Per2 gene by ovarian steroid hormones. It is well known that eCG injection causes the 
formation of antral follicles in ovaries that produce estradiol, and hCG injection thereafter 
results in luteinization of ovarian follicles that produce large amounts of progesterone. The 
large amounts of estradiol and progesterone promote proliferation and differentiation in the 
uterus. The stroma cells proliferate in the eCG-primed rat uterus, compared to those in the 
hCG-primed rat uterus. The stroma cells were treated with dexamethasone or forskolin. In 
the stroma cells prepared from intact immature rats, cyclic Per2 oscillation was observed 
after exposure to dexamethasone or forskolin (Fig 3, a & e) (Hirata et al., 2009). This suggests 
that the glucocorticoid response element (GRE) and cAMP response element (CRE) sites in 
the rat Per2 promoter are operative and transactivate the transcription of the Per2 gene 
(Travnickova-Bendova et al., 2002; Yamamoto et al., 2004). Although the second oscillation 
in the stroma cells was delayed compared to that in the ovarian cells (He et al., 2007c), the 
circadian oscillator was operative with approximately 24 h per cycle. In contrast, the stroma 
cells from eCG-primed rats exhibited an irregular rhythm of Per2 oscillation with a smaller 
trough (Fig. 3, b & f). Disrupted oscillation was also observed in the cells 2 days after hCG 
priming subsequent to eCG priming (Fig. 3, c & g). However, in the cells of rats 4 days after 
hCG priming subsequent to eCG priming, the disrupted oscillation recovered to a rhythmic 
 
 
Fig. 3. Circadian oscillation of Per2-dLuc in uterine endometrial stroma cells prepared from 
intact or gonadotropin-primed rats. Immature rats were primed with or without 25IU hCG 
following 50IU eCG, and the stroma cells isolated were cultured for 48 h with medium 
containing 10% FBS. The cells were treated with dexamethasone (a-d) or forskolin (e-h), and 
then subjected to real-time monitoring of bioluminescence. a, e: stroma cells from intact rats; 
b, f: cells from rats 2 days after priming with eCG; c, g: cells from rats 2 days after priming 
with hCG subsequent to eCG priming; d, h: cells from rats 4 days priming with hCG 
subsequent to eCG priming. 
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pattern with a 24-h cycle, similar to those observed in intact immature rats (Fig. 3, d & h). 
Chronic treatment with estradiol is known to disrupt the circadian rhythms of Per1 and Per2 
expression in the liver, kidney and uterus (Nakamura et al., 2005). Furthermore, the phase of 
the estrous cycle has a profound effect on the oscillation of the PER2 protein within the brain 
(Perrin et al., 2006). The circadian oscillator may be operative in the stroma cells after 
progesterone administration, through the transcriptional and feedback loops of the clock 
system. Consequently, it is possible that estradiol does not induce rhythmic Per2 oscillation, 
whereas progesterone promotes the rhythmic pattern. 
5. Expression of Per1 gene in uterine cells by ovarian steroids  
The uterus undergoes profound remodelling, implicating cyclic proliferation, differentiation 
and differential gene expression dependent on the levels of circulating ovarian steroids. 
Recent studies have demonstrated that circadian clock genes are rhythmically expressed in 
the uterus (Nakamura et al., 2005; Dolatshad et al., 2006). Expression of Per1 mRNA was 
analyzed by in situ hybridization in different compartments of the uterus at ZT 0 and ZT 8 
(He et al., 2007c). The expression could be readily detected in both the endometrium and 
myometrium at ZT 0 and ZT 8 (Fig. 4). Strong signals were observed in the luminal 
epithelium and glandular epithelium, as compared to that in the stromal cell layer. The 
staining intensity of Per1 mRNA was approximately two-fold higher at ZT 8 than at ZT 0 in 
the stroma, luminal epithelium and myometrium compartments. It is noted that the staining 
signal did not apparently change at ZT 0 and ZT 8 in the glandular epithelium 
compartment. This suggests the lack of rhythmical clockwork in the control of uterine 
glandular physiology. The effects of estradiol and progesterone on the expression of Per1  
 
 
Fig. 4. Representative photomicrographs of in situ hybridization analyses for Per1 mRNA in 
diestrous uteri. The uterine samples were obtained at ZT0 (a, b) and ZT8 (c, d). Dark shades 
show the staining of Per1 mRNA. No signal was obtained in the uteri stained with a sense 
probe. S, stroma; LE, luminal epithelium; GE, glandular epithelium; M, myometrium. Scale 
bars, 100 µm. 
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mRNA were evaluated in the uteri of ovariectomied rats. All the uteri were collected at ZT 0 
after a single injection of ovarian steroids. In situ hybridization analysis revealed that the 
estradiol-primed uteri exhibited much stronger staining in the luminal epithelium, 
glandular epithelium and myometrium compartments (Fig. 5). However, the staining signal 
was weak in the stroma compartment. In addition, treatment with an ER antagonist 
(ICI182,780) caused a decrease of the staining intensity of Per1 mRNA in all examined 
compartments (Fig. 6). This indicates that the Per1 expression is at least partly through the 
 
 
Fig. 5. Representative photomicrographs of in situ hybridization analyses for Per1 mRNA 
(A) and immunofluorescent analyses for PER1 protein (B) in the uteri treated with estradiol 
(E2) or progesterone (P4). At ZT0, the OVX rats were injected subcutaneously with 100 µl 
sesame oil-containing vehicle (a, b, g), 50 µg/kg E2 (c, d, h), or 10 mg/kg P4 (e, f, i), and 
uteri were removed after 24 h. The relative changes of Per1 mRNA staining are presented as 
means ± SEM of three independent sections. S, stroma; LE, luminal epithelium; GE, 
glandular epithelium; M, myometrium. Scale bars, 100 µm. 
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Fig. 6. Representative photomicrographs of in situ hybridization analyses for Per1 mRNA in 
the uteri treated with estradiol (E2), E2 + ICI182780, progesterone (P4), or P4 + RU486. At 
ZT0, the OVX rats were injected subcutaneously with 100 µl sesame oil-containing vehicle, 3 
mg/kg ICI182780, or 30 mg/kg RU486, after 2 h, followed by injection with 50 µg/kg E2 or 
10 mg/kg P4. The uteri were collected at ZT0 the following day. The relative changes of Per1 
mRNA staining are presented as means ± SEM of three independent sections. S, stroma; LE, 
luminal epithelium; GE, glandular epithelium; M, myometrium. Scale bars, 100 µm. 
*Statistical significance vs. the control (p<0.05). 
ER-mediated pathway. The differences in Per1 mRNA expression among the compartments 
might result from differential expression of ER. Actually, the ER mRNA or protein is 
expressed at higher levels in the luminal epithelium, glandular epithelium and myometrium 
compartments than in the stroma at 24 h after estradiol administration (Nephew et al., 2000). 
This pattern of ER distribution, to some extent supports the current Per1 mRNA expression 
profile in the uterus in response to estradiol. On the other hand, progesterone 
administration resulted in intense staining in the stroma, luminal epithelium and glandular 
epithelium compartments, but not in the myometrium compartment (Fig. 5). Treatment with 
a PR antagonist (RU486) remarkably inhibited Per1 mRNA expression in the stroma and 
glandular epithelium compartments (Fig. 6). These observations indicate that ER and PR 
might mediate estradiol- and progesterone-regulated Per1 expression in the uterus, 
respectively. Immunofluorescent staining for the PER1 protein was performed in estradiol- 
and progesterone-administered uteri. In the control uteri, relatively stronger staining was 
observed in the luminal epithelium and glandular epithelium compartments, with weak 
staining in the stroma. With estradiol treatment, the PER1 protein was more intensively 
expressed in the stroma, luminal epithelium and glandular epithelium compartments. 
Treatment with progesterone also resulted in stronger immunostaining of PER1 in the 
stroma, luminal epithelium and glandular epithelium compartments. Immunohistochemical 
observations of PER1 expression in response to ovarian steroids were similar to the results 
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revealed by in situ hybridization. The activated expression of Per1 by ovarian steroids might 
result from the direct binding of receptors for estrogen and progesterone to some potential 
elements (ERE, PRE) in the Per1 promoter. There is no consensus ERE (5’-
GGTCANNNTGACC-3’) site, but some ERE half-sites are located in the 5’ flanking region of 
the Per1 promoter (Nakamura et al. 2005). 
6. Expression and distribution of the PER2 protein in the uterus during 
gestation 
In studies on the expression pattern of the Per2 mRNA in the uterus of estrous mice, a 
robust daily variation was reported with a peak around early dark periods (Dolatshad et al., 
2006). However, little is known about whether the circadian clockwork is modulated during 
gestation. In rodents and humans, uterine endometrial stroma cells undergo proliferation 
and differentiation into decidual cells, ultimately leading to the formation of the placenta. 
We previously described that the rhythmic Per2-dLuc oscillation is not observed in the 
stroma cells undergoing decidualization induced by medroxyprogesterone acetate plus N6, 
2-O-dibutyryl adenosine 3’:5’-cyclic monophosphate (He et al., 2007b). Stroma cells isolated 
from pregnant rats on day 4.50 of gestation are proliferative in culture. Cells isolated from the 
transgenic rats were employed to analyze circadian oscillation on day 4.50 (ZT 4) and day 6.50 
(ZT 4). On day 4.50, treatment of the stroma cells with dexamethasone caused the generation 
of circadian Per2-dLuc oscillation. This indicates that GREs in the rat Per2 promoter are 
functional and transactivate the transcription of the Per2 gene (Travnickova-Bendova et al., 
2002; Yamamoto et al., 2004; He et al., 2007b). Although the second oscillation in the stroma 
cells is delayed compared with that of ovarian cells (He et al., 2007b), the circadian oscillation 
was obvious, with approximately 24 h per cycle at least during the stage of implantation. In 
contrast, the circadian oscillation was attenuated in the decidualizing cells only 2 days after 
implantation. However, the times of each oscillation in the stroma cells on day 4.50 and day 
6.50 of gestation were mostly identical. The expression and distribution of the PER2 protein 
were investigated by fluorescent immunohistochemistry in different compartments of the uteri 
(day 4.5) at ZT 4 and ZT12 (Uchikawa et al., 2011). A strong immunostaining signal was 
detected in the luminal epithelium, as compared to that in the stroma cell layer (Fig. 7), which 
was similar to the distribution of the PER1 protein. The cytoplasm of the luminal epithelium 
especially exhibited a strong signal at both ZT4 and ZT12. This suggests a continuous 
expression of the PER2 protein. On the other hand, in the stromal cell layer, immunostaining 
signals were observed in both the nuclei and cytoplasms at ZT4, whereas signals were 
observed predominantly in the nuclei at ZT12. Fluorescent immunohistochemical studies may 
support the circadian rhythm of the PER2 protein at least in the stroma cell layer. In contrast to 
the implantation stage, no significant rhythm of the PER2 protein was found during the 
decidualization stage (day 6.5 to day 6.8). Fluorescent immunohistochemistry revealed a 
strong signal in the cytoplasm of the luminal epithelium at both ZT4 and ZT12 (Fig. 7). As 
compared to the implantation stage, immunostaining signals were observed predominantly in 
the nuclei of stroma cell layers at both ZT4 and ZT12. 
7. Circadian rhythm in uterine endometrial stroma cells during gestation 
The uterine endometrial stroma cells prepared from several stages of gestation (pregnancy 
days 2.5, 4.5 and 6.5; P2.5, P4.5, P6.5, respectively) exhibited different responses to 
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Fig. 7. Circadian rhythm of the PER2 protein and representative photomicrographs of 
immunofluorescent analyses for PER2 protein in the uteri of pregnant rats during the stages 
of implantation and decidualization. A, Pregnant rats were killed at 4-h intervals over a 
daily cycle (ZT0, 0800h). Proteins (30 µg) prepared from a part of the uterine horns were 
separated on SDS-PAGE, and analyzed by immunodetection using anti-mPER2 antibody. 
Data are means ± SEM from three independent experiments normalized to the values given 
by α-tubulin. Values with different letters are significantly different (p<0.05). Shaded areas, 
during the night. B, Parts of uterine horns at ZT4 and ZT12 were subjected to fluorescent 
immunohistochemistry. The square regions shown in HE were magnified from a serial 
section subjected to immunofluorescent studies of the PER2 protein (red) and Hoechst 
staining (blue). Scale bars: 150 µm (HE), 50 µm (PER2, PER2/Nuclei). 
dexamethasone and forskolin. Circadian oscillation was generated in these cells, albeit with 
a continuous decrease of amplitude (Fig. 8). However, the response to forskolin showed a 
greater decrease from P2.5 to P6.5 than the response to dexamethasone. This suggests that 
the effect of cAMP signalling on the circadian rhythm of clock genes is weak. Of interest, the 
oscillatory intensity was low in the stroma cells at day 7, at which these cells undergo 
decidualization. This suggests that the circadian oscillator is impaired in the stroma cells 
during decidualization. During the stage of implantation, dramatic changes are observed in 
the expression of hypoxia-inducible factor 1α (HIF1α) and vascular endothelial growth 
factor (VEGF), angiogenesis, down-regulation of anti-adhesion proteins, and up-regulation 
of adhesion proteins. Several of these genes are known to interact with the clock gene 
transcription factors. BMAL1 can dimerize with HIF1α and may bind to the hypoxia 
response elements in the promoters and drive the transcription of target genes (Hogenesch 
et al., 1998). On the other hand, during the stage of decidualization, the decidual cells 
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Fig. 8. Profiles of Per2-dLuc oscillation in uterine endometrial stroma cells prepared from 
pregnant rats at day 2.5 (P2.5), day 4.5 (P4.5) and day 6.5 (P6.5) of gestation. After the stroma 
cells were cultured for 48 h, they were treated with dexamethasone (DXM) or forskolin 
(FSK) for 2 h, and then subjected to real-time monitoring of bioluminescence.  
express many peptides including desmin, IGF-binding proteins, tumor necrosis factor, and 
decidual prolactin-related protein. Some of these factors may be controlled under the 
circadian clockwork. For example, the Vegf gene has at least 7 E-box and E-box-like sites 
within the -5000 upstream of the transcription start site (NC_005108). Circadian oscillation 
of Vegf mRNA was observed during the stage of implantation, whereas it was not seen 
during the stage of decidualization (Fig. 9). In addition, the circadian rhythm of the Vegf 
mRNA was consistent with that of the Per2 mRNA (Uchikawa et al., 2011). This suggests a 
clock regulation of the Vegf gene. Clearly, the circadian oscillator is down-regulated in the 
uterine endometrial stroma cells during decidualization. This strongly suggested that 
cellular differentiation in the stroma cells interferes with the circadian clockwork.  
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Fig. 9. Circadian rhythms of Per2 and Vegf transcripts in the uterine tissues of pregnant rats 
during the implantation and decidualization stages. RNA was extracted from a part of 
uterine horns and reverse transcribed. The resulting cDNA was used for real-time qPCR for 
Per2 and Vegf mRNAs. (A) Left, Per2 mRNA expression was significantly altered in the 
uterine tissues of pregnant rats during implantation (day 4.33—5.16 of gestation). Right, Per2 
mRNA expression did not change significantly in the uterine tissues of pregnant rats during 
decidualization (day 6.33—7.16 of gestation). (B) Left, Vegf mRNA expression was 
significantly altered in the uterine tissues of pregnant rats during implantation. Right, Vegf 
mRNA expression did not significantly change in the uterine tissues of pregnant rats during 
decidualization. Data are means ± SEM from three independent experiments normalized to 
the values given by Gapdh. Values with different letters are significantly different (p<0.05).  
8. Conclusions 
The circadian pacemaker undergoes changes in ovarian and uterine cells during cellular 
differentiation as follows. Firstly, the circadian pacemaker in ovarian cells is modulated during 
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follicular development. Secondly, ovarian steroids promote expression of Per1 and Per2 in 
uterine endometrial stroma cells. Especially, progesterone may recover the deregulation of the 
circadian oscillator induced by eCG-produced estradiol. Thirdly, the circadian oscillator is 
down-regulated in the uterine endometrial stroma cells during decidualization. The alteration 
of the circadian pacemaker in the ovarian and uterine cells results largely from hormonal 
inputs such as gonadotropins and ovarian steroids, possibly via the regulatory elements such 
as the cAMP response element and steroid hormone response element half-sites (Fig. 10). 
However, cell differentiation may also disrupt the circadian pacemaker. 
 
 
 
 
 
 
 
 
 
Fig. 10. Hormonal regulation of circadian clock system in cell functions via identified 
transcriptional and posttranscriptional regulatory processes. The CLOCK-BMAL1 
heterodimers bind to the canonical E-box element of clock genes and initiate the 
transcription activities of these genes. In addition to the E-box and D-box elements, many 
SHE half and CRE sites are located at the upstream of clock genes. As the input pathway, 
hormonal and environmental signals are transmitted to the pacemaker. The clock system 
may contribute to the progress of follicular development, luteinization and luteolysis, and 
steroid hormone-induced proliferation and differentiation of uterine cells through 
fluctuating hormones. SH: steroid hormones, AC: adenylate cyclase. 
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